EUVIMEDEUVIMED entdecken
Crossref

LncRNA PVT1 drives macrophage polarization and triple-negative breast cancer progression via PPARγ-mediated transcriptional activation​

Xiaobin Zhang, Jingru Yang, Junqiang Niu, Xu Hui, Weize Kong, Xiaoling Ling, Fei Su, Yongbin Lu

Apoptosis · 2026-01 · 31 (1)

DOI: 10.1007/s10495-025-02232-8 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Apoptosis, online erschienen am 10.01.2026. Verfasst von Xiaobin Zhang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Breast Surgery, The First Hospital of Lanzhou University, Lanzhou, 730000, China. Hauptthemen laut MEDLINE: PPAR gamma, RNA, Long Noncoding, Triple Negative Breast Neoplasms, Macrophages. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 88 Literaturangaben. Gefördert von: The Natural Science Foundation of Gansu Province, The National Natural Science Foundation of China, The Fundamental Research Funds for the Central Universities.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Triple-negative breast cancer (TNBC) is a clinically aggressive subtype with limited therapeutic strategies. Although long non-coding RNAs (lncRNAs) are increasingly linked to tumor progression, their regulatory role in macrophage polarization during TNBC remains unclear. This study investigates the molecular interplay between lncRNA PVT1 and PPARγ in driving macrophage reprogramming during TNBC progression. Utilizing an orthotopic TNBC mouse model, single-cell RNA sequencing (scRNA-seq) identified nine distinct cell types, with pseudotime trajectory analysis revealing macrophage accumulation in advanced tumor stages. Reannotation of macrophages highlighted M2-like polarization dominance during TNBC development. Bulk sequencing of TNBC macrophages and integrated GEO/TCGA analyses identified PPARγ as a key regulator and PVT1 as a differentially expressed lncRNA in TNBC versus normal tissues. In vitro experiments with THP-1/U937 macrophages demonstrated that PVT1 knockdown or PPARγ modulation altered macrophage polarization, subsequently affecting MDA-MB-231 and MCF-7 breast cancer cell proliferation and invasion. Mechanistically, RNA/DNA pulldown and luciferase assays confirmed that PVT1 recruits NOP56 and E2F1 to form a transcriptional complex, enhancing E2F1-driven PPARγ expression. In vivo, orthotopic tumors generated from PVT1-silenced THP-1/MDA-MB-231 cell mixtures exhibited suppressed growth, increased M1-like macrophages, and elevated apoptosis (TUNEL assay), whereas PPARγ overexpression accelerated tumor progression with M2-dominant infiltration (flow cytometry). These findings establish lncRNA PVT1 as a critical epigenetic scaffold coordinating NOP56-E2F1-PPARγ signaling to polarize macrophages toward a pro-tumorigenic M2 phenotype, thereby fueling TNBC aggressiveness. This study unveils novel therapeutic targets for TNBC by disrupting the PVT1-PPARγ axis to rebalance macrophage dynamics and induce tumor-suppressive immunity.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PPAR gammaRNA, Long NoncodingTriple Negative Breast NeoplasmsMacrophagesTranscriptional ActivationHumansAnimalsFemaleMiceGene Expression Regulation, NeoplasticCell ProliferationDisease ProgressionCell Line, TumorMacrophage ActivationMDA-MB-231 CellsMCF-7 Cells

Stichwörter der Autor:innen

Long Non-Coding RNA PVT1Macrophage polarizationPPARγSingle-Cell RNA sequencingTriple-Negative breast cancer

Substanzen

PPAR gammaRNA, Long NoncodingPVT1 long-non-coding RNA, humanPPARG protein, human

Autor:innen und Institutionen

  • Department of Breast Surgery, The First Hospital of Lanzhou University, Lanzhou, 730000, China.
  • Department of Oncology, The First Hospital of Lanzhou University, Lanzhou, 730000, China.
  • Department of Traditional Chinese Medicine, The First Hospital of Lanzhou University, Lanzhou, 730000, China.
  • School of Public Health, Lanzhou University, No. 222 Tianshui South Road Chengguan District, Lanzhou, 730000, Gansu Province, China.
  • The First Hospital of Lanzhou University, Lanzhou University, 1 Donggang West Road, Chengguan District, Lanzhou, 730000, Gansu Province, China.
  • Department of Oncology, The First Hospital of Lanzhou University, Lanzhou, 730000, China. sufei19881216@163.com.

Förderung

  • The Natural Science Foundation of Gansu Province
  • The National Natural Science Foundation of China
  • The Fundamental Research Funds for the Central Universities
  • Gansu Provincial Department of Education Project

Zitieren

APA

Zhang, X., Yang, J., Niu, J., Hui, X., Kong, W., Ling, X., Su, F., & Lu, Y. (2026). LncRNA PVT1 drives macrophage polarization and triple-negative breast cancer progression via PPARγ-mediated transcriptional activation​. Apoptosis, 31(1). https://doi.org/10.1007/s10495-025-02232-8

Vancouver

Zhang X, Yang J, Niu J, Hui X, Kong W, Ling X, et al. LncRNA PVT1 drives macrophage polarization and triple-negative breast cancer progression via PPARγ-mediated transcriptional activation​. Apoptosis. 2026;31(1). doi:10.1007/s10495-025-02232-8

BibTeX
@article{Zhang2026,
  author = {Zhang, Xiaobin and Yang, Jingru and Niu, Junqiang and Hui, Xu and Kong, Weize and Ling, Xiaoling and Su, Fei and Lu, Yongbin},
  title = {LncRNA PVT1 drives macrophage polarization and triple-negative breast cancer progression via PPARγ-mediated transcriptional activation​},
  journal = {Apoptosis},
  year = {2026},
  volume = {31},
  number = {1},
  doi = {10.1007/s10495-025-02232-8}
}
Kostenlos starten →